Clinical Trials Directory

Trials / Completed

CompletedNCT01780870

Weight Loss Study-Mechanism Underlying the Improvement of Insulin Resistance in Response to Weight Loss

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
5 (actual)
Sponsor
Beth Israel Deaconess Medical Center · Academic / Other
Sex
All
Age
18 Years – 50 Years
Healthy volunteers
Accepted

Summary

The main purpose of this study is to assess factors mediating the changes in insulin sensitivity and glucose tolerance before and after 10 lbs ± or 2% weight loss reduction as well as 2, 3, 6, 12, and 24 months after initiation of a low calorie diet. The investigators will also study the following: 1. The impact of diet induced weight loss on hormones/adipokine levels 2. The impact of diet induced weight loss on leptin tolerance

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTWeight loss group (Full meal replacement products)In the intervention arm of this non randomized, open label study to assess the effects of weight loss on insulin sensitivity and leptin tolerance subjects will use full meal replacement products (1280-1320kcal/day). Subjects will be on the full meal replacement products only, for the first 12 weeks, between 13 to 19 weeks they will be transitioned to regular food, from 19 weeks and going forward they will be on chronic maintenance phase

Timeline

Start date
2012-09-01
Primary completion
2017-01-01
Completion
2017-01-01
First posted
2013-01-31
Last updated
2017-08-07
Results posted
2017-08-07

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01780870. Inclusion in this directory is not an endorsement.